5,231 results match your criteria Cephalalgia[Journal]


The influence of friendship on migraine in young adolescents: A social network analysis.

Cephalalgia 2020 Jul 7:333102420940700. Epub 2020 Jul 7.

Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.

Objective: The current study explored whether the chances of having migraine are influenced by a youth's friendship with a migraineur.

Methods: The study was centered on a community-based non-referral cohort of eighth graders from two middle schools in Taiwan. Among the 642 recruited adolescent students, 610 (95%) (mean age 14. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420940700DOI Listing

Medication overuse headache: Divergent effects of new acute antimigraine drugs.

Cephalalgia 2020 Jul 2:333102420938655. Epub 2020 Jul 2.

Headache Group, Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420938655DOI Listing

Ubrogepant does not induce latent sensitization in a preclinical model of medication overuse headache.

Cephalalgia 2020 Jul 2:333102420938652. Epub 2020 Jul 2.

Department of Pharmacology, Arizona Health Sciences Center, University of Arizona, Tucson, AZ, USA.

Background: Ubrogepant, a small-molecule calcitonin gene-related peptide receptor antagonist, was recently approved as an oral medication for the acute treatment of migraine. This study aimed to determine whether ubrogepant shows efficacy in a preclinical model of migraine-like pain and whether repeated oral administration of ubrogepant induces latent sensitization relevant to medication overuse headache in rats.

Methods: A "two-hit" priming model of medication overuse headache was used. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420938652DOI Listing

Localization of TRPA1 channels and characterization of TRPA1 mediated responses in dural and pial arteries in vivo after intracarotid infusion of NaS.

Cephalalgia 2020 Jul 1:333102420937724. Epub 2020 Jul 1.

Department of Neurology, Danish Headache Center, Rigshospitalet, Glostrup, Denmark.

Background: The Transient Receptor Potential Ankyrin 1 (TRPA1) channel might play a role in migraine. However, different mechanisms for this have been suggested. The purpose of our study was to investigate the localization and significance of TRPA1 channels in rat pial and dural arteries. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420937724DOI Listing

Increased severity of closed head injury or repetitive subconcussive head impacts enhances post-traumatic headache-like behaviors in a rat model.

Cephalalgia 2020 Jun 29:333102420937664. Epub 2020 Jun 29.

Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Centre, Boston, MA, USA.

Introduction: Posttraumatic headache is one of the most common, debilitating, and difficult symptoms to manage after a traumatic head injury. The development of novel therapeutic approaches is nevertheless hampered by the paucity of preclinical models and poor understanding of the mechanisms underlying posttraumatic headache. To address these shortcomings, we previously characterized the development of posttraumatic headache-like pain behaviors in rats subjected to a single mild closed head injury using a 250 g weight drop. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420937664DOI Listing

Two-hour infusion of vasoactive intestinal polypeptide induces delayed headache and extracranial vasodilation in healthy volunteers.

Cephalalgia 2020 Jun 27:333102420937655. Epub 2020 Jun 27.

Danish Headache Center, Department of Neurology, Rigshospitalet Glostrup Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Background: In recent years, vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptides (PACAPs) have gained special interest in headache science. VIP and PACAPs (two isoforms, PACAP27 and PACAP38) are related in structure and function, as are their receptors, but they show differences in vasodilating- and headache-inducing properties. Intravenous infusion of PACAP27 or PACAP38, but not VIP, induces a long-lasting dilation of cranial arteries and delayed headache. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420937655DOI Listing

IHC 2019 Author index.

Authors:

Cephalalgia 2019 Sep;39(1_suppl):339-357

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102419861204DOI Listing
September 2019

IHC 2019 Late Breaking Author Index.

Authors:

Cephalalgia 2019 Sep;39(1_suppl):428-432

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102419880418DOI Listing
September 2019

Serum levels of allopregnanolone, progesterone and testosterone in menstrually-related and postmenopausal migraine: A cross-sectional study.

Cephalalgia 2020 Jun 26:333102420937742. Epub 2020 Jun 26.

Unit of Medical Toxicology, Headache Centre and Drug Abuse; Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.

Background: Reduced blood or cerebrospinal fluid levels of allopregnanolone are involved in menstrual cycle-linked CNS disorders, such as catamenial epilepsy. This condition, like menstrually-related migraine, is characterized by severe, treatment-resistant attacks. We explored whether there were differences in allopregnanolone, progesterone and testosterone serum levels between women with menstrually-related migraine (MM, n = 30) or postmenopausal migraine without aura who had suffered from menstrually-related migraine during their fertile age (PM, n = 30) and non-headache control women in fertile age (FAC, n = 30) or post-menopause (PC, n = 30). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420937742DOI Listing

Evaluation of LY573144 (lasmiditan) in a preclinical model of medication overuse headache.

Cephalalgia 2020 Jun 24:333102420920006. Epub 2020 Jun 24.

Mayo Clinic, Scottsdale, AZ, USA.

Background: Medication overuse is a significant issue that complicates the treatment of headache disorders. The most effective medications for the acute treatment of migraine all have the capacity to induce medication overuse headache (MOH). Novel acute migraine-specific treatments are being developed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420920006DOI Listing

Have you ever experienced a headache of any kind?

Authors:
Jonathan H Smith

Cephalalgia 2020 Jun 20:333102420933978. Epub 2020 Jun 20.

Mayo Clinic, Department of Neurology, Scottsdale, AZ, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420933978DOI Listing

Letter to the editor regarding "Have you ever experienced a headache of any kind?"

Cephalalgia 2020 Jun 20:333102420933974. Epub 2020 Jun 20.

Danish Headache Center, Neurological Department, Copenhagen University Hospital, Rigshospitalet, Glostrup, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420933974DOI Listing

Migraine presenting as isolated facial pain: A prospective clinical analysis of 58 cases.

Cephalalgia 2020 Jun 17:333102420933277. Epub 2020 Jun 17.

Orofacial Pain Service, Department of Oral Surgery, King's College Hospital NHS Foundation Trust, London, UK.

Background: Sparse evidence has detailed the clinical phenotype of migraine presenting as isolated facial pain. This was a prospective audit, part of our multidisciplinary facial pain service evaluation, aiming to phenotype patients with migraine presenting as isolated facial pain who attended our service between 2013 and 2018.

Results: Fifty-eight patients were diagnosed with migraine with isolated facial pain (F = 46, 79. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420933277DOI Listing

No efficacy of transcranial direct current stimulation on chronic migraine with medication overuse: A double blind, randomised clinical trial.

Cephalalgia 2020 Jun 14:333102420931050. Epub 2020 Jun 14.

Neuroalgology Unit, Headache Centre, Fondazione IRCCS Istituto Neurologico "Carlo Besta", Milan, Italy.

Background: Transcranial direct current stimulation was suggested to provide beneficial effects in chronic migraine, a condition often associated with medication overuse for which no long-term therapy is available.

Methods: We conducted a randomised controlled trial to assess long-term efficacy of transcranial direct current stimulation. Adults diagnosed with chronic migraine and medication overuse were assigned to receive in a 1:1:1 ratio anodal, cathodal, or sham transcranial direct current stimulation daily for five consecutive days, along with standardised drug withdrawal protocol. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420931050DOI Listing

Reply to letter to the editor: Insights into chronic migraine pathophysiology - what measures of gray matter reveal.

Cephalalgia 2020 Jun 14:333102420933262. Epub 2020 Jun 14.

Department of Neurology, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420933262DOI Listing

Impaired wound healing in a migraine patient as a possible side effect of calcitonin gene-related peptide receptor antibody treatment: A case report.

Cephalalgia 2020 Jun 14:333102420933571. Epub 2020 Jun 14.

Department of Neurology, West German Headache Center, University of Duisburg-Essen, Essen, Germany.

Introduction: Wound healing disturbances as possible side effects of calcitonin gene-related peptide (CGRP) antibody treatment have been discussed previously but not yet described in humans. Basic research suggests that calcitonin gene-related peptide plays an important role in keratinocyte migration, vascularization and immune response and lack of calcitonin gene-related peptide may lead to impaired wound healing.

Case: A 51-year-old female migraine patient was treated with the CGRP receptor antibody erenumab for 6 months, which led to a relevant reduction of migraine days. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420933571DOI Listing

Insights into chronic migraine pathophysiology - what measures of gray matter reveal.

Cephalalgia 2020 Jun 14:333102420933263. Epub 2020 Jun 14.

Department of Neurology and Neurological Sciences, Headache and Facial Pain Program, Stanford University, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420933263DOI Listing

J-A Barré's historic article "On posterior cervical sympathetic syndrome": A translation from French.

Authors:
Vladimir Gorelov

Cephalalgia 2020 Jun 12:333102420931790. Epub 2020 Jun 12.

Spire Elland Hospital, Elland, UK.

Barré's 1926 report "Sur un syndrome sympathique cervicale postérieure et sa cause fréquente: l'arthrite cervicale" is arguably the first description of what we now call cervicogenic headache. Barré's contribution to the subject and significant insights, which have stood the test of time, are insufficiently recognised. This article is an English translation of Barré's French original. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420931790DOI Listing

Reliability of orofacial quantitative sensory testing for pleasantness and unpleasantness.

Cephalalgia 2020 Jun 2:333102420929700. Epub 2020 Jun 2.

Section of Orofacial Pain and Jaw Function, Department of Dentistry and Oral Health, Aarhus University, Aarhus, Denmark.

Background: Quantitative sensory testing protocols for perceptions of pleasantness and unpleasantness based on the German Research Network on Neuropathic Pain protocol were recently introduced. However, there are no reliability studies yet published.

Aim: To evaluate the intra-examiner (test-retest) and inter-examiner reliability for orofacial pleasantness and unpleasantness quantitative sensory testing protocols. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420929700DOI Listing

Differences in pituitary adenylate cyclase-activating peptide and calcitonin gene-related peptide release in the trigeminovascular system.

Cephalalgia 2020 Jun 2:333102420929026. Epub 2020 Jun 2.

Department of Clinical Experimental Research, Glostrup Research Institute, Rigshospitalet Glostrup, Glostrup, Denmark.

Background: Several neurotransmitters are expressed in the neurons of the trigeminal ganglion. One such signalling molecule is the pituitary adenylate cyclase-activating peptide (PACAP). PACAP signalling has been suggested to have a possible role in the pathophysiology of primary headaches. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420929026DOI Listing

Oxytocin as a regulatory neuropeptide in the trigeminovascular system: Localization, expression and function of oxytocin and oxytocin receptors.

Cephalalgia 2020 Jun 2:333102420929027. Epub 2020 Jun 2.

Department of Clinical Experimental Research, Glostrup Research Institute, Rigshospitalet, Glostrup, Denmark.

Background: Recent clinical findings suggest that oxytocin could be a novel treatment for migraine. However, little is known about the role of this neuropeptide/hormone and its receptor in the trigeminovascular pathway. Here we determine expression, localization, and function of oxytocin and oxytocin receptors in rat trigeminal ganglia and targets of peripheral (dura mater and cranial arteries) and central (trigeminal nucleus caudalis) afferents. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420929027DOI Listing

Dopaminergic symptoms in migraine: A cross-sectional study on 1148 consecutive headache center-based patients.

Cephalalgia 2020 Jun 2:333102420929023. Epub 2020 Jun 2.

Department of Human Sciences and Quality of Life Promotion, San Raffaele Roma Open University, Rome, Italy.

Background: Dopaminergic symptoms may be extremely pronounced in some migraine patients during the attack, representing a major source of disability.

Objectives: We aimed to carefully characterize the clinical picture of migraine patients with dopaminergic symptoms in a large patients' population as a putative migraine endophenotype, allowing more precise disease management, treatment and outcome prediction.

Methods: We screened 1148 consecutive tertiary care episodic and chronic migraine patients with face-to-face interviews collecting thorough data on lifestyle, socio-demographic factors, and clinical migraine features. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420929023DOI Listing

Characteristics of cortical spreading depression and c-Fos expression in transgenic mice having a mutation associated with familial hemiplegic migraine 2.

Cephalalgia 2020 Jun 2:333102420929028. Epub 2020 Jun 2.

Department of Neurology, Keio University School of Medicine, Tokyo, Japan.

Background: Cortical spreading depression is thought to be the underlying mechanism of migraine aura. In 2006, three relatives having the point mutation E700K in exon 15 were diagnosed with familial hemiplegic migraine 2 characterized by complicated forms of aura. Here, we generated a transgenic mouse model having the human E700K mutation in the orthologous gene. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420929028DOI Listing

Reply to Letter to the Editor, "Creatine loading for chronic migraine?"

Cephalalgia 2020 Jun 2:333102420931051. Epub 2020 Jun 2.

National Yang-Ming University, Brain Research Center, Taipei, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420931051DOI Listing

Creatine loading for chronic migraine?

Authors:
Sergej M Ostojic

Cephalalgia 2020 Jun 2:333102420931055. Epub 2020 Jun 2.

FSPE Applied Bioenergetics Lab, University of Novi Sad, Novi Sad, Serbia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420931055DOI Listing

Determination of psychosocial factors in cluster headache - construction and psychometric properties of the Cluster Headache Scales (CHS).

Cephalalgia 2020 Jun 2:333102420928076. Epub 2020 Jun 2.

Migraine and Headache Clinic Königstein, Königstein, Germany.

Background: Cluster headache (CH) is clinically associated with considerable psychosocial burden. However, instruments to assess and characterize psychosocial factors in cluster headache more specifically are lacking. This study aimed to develop a self-report questionnaire, which assesses the broadest possible spectrum of psychosocial factors in cluster headache, the Cluster Headache Scales (CHS). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420928076DOI Listing

The depiction of migraine visual aura on the internet.

Cephalalgia 2020 May 27:333102420927027. Epub 2020 May 27.

Danish Headache Center and Department of Neurology, Rigshospitalet Glostrup, Copenhagen, Denmark.

Introduction: The most common and multifaceted migraine aura symptoms are visual disturbances. Health information is one of the most popular topics on the internet but the quality and reliability of publicized information is unknown. The aim of this study was to analyze images of migraine aura on Google to determine the frequency of correct presentations of visual aura and distribution of visual aura phenotypes. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420927027DOI Listing

Positional headache induced by isolated middle cerebral artery dissection: Two case reports.

Cephalalgia 2020 May 27:333102420927028. Epub 2020 May 27.

Department of Neurology, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Republic of Korea.

Background: Isolated middle cerebral artery dissection is uncommon and occurs in patients reporting headaches as the only symptom. This makes intracranial artery dissection challenging to diagnose and treat. Case description: We describe two cases of positional headache caused by isolated middle cerebral artery dissection, confirmed using high-resolution magnetic resonance imaging. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420927028DOI Listing

Infectious and inflammatory disorders might increase the risk of developing idiopathic intracranial hypertension - a national case-control study.

Cephalalgia 2020 May 25:333102420928079. Epub 2020 May 25.

Department of Clinical Neuroscience, Karolinska Institutet and Department of Neurology, Karolinska University Hospital, Sweden.

Objective: To investigate whether conditions causing inflammatory activation are associated with increased risk of idiopathic intracranial hypertension.

Methods: All newly diagnosed idiopathic intracranial hypertension patients (cases) in Sweden between 2000-2016 were identified using pre-determined algorithms (n = 902) and matched with five controls from the general population and five individuals with an obesity diagnosis (n = 4510) for age, sex, region, and vital status. National health registers provided information on infections, inflammatory disorders and dispensed medications. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420928079DOI Listing

Cerebellar syndrome after occipital nerve block. A case report.

Cephalalgia 2020 May 25:333102420929015. Epub 2020 May 25.

Neurology Unit, Department of Medicine, Hopitaux Robert Schuman, Luxembourg, Luxembourg.

Background: Occipital nerve blocks are commonly used in the treatment of different types of refractory headaches. The procedure is considered safe, and serious complications have rarely been described.

Case Presentation: We report a serious complication of occipital nerve blockade secondary to the penetration of local anesthetic and non-steroidal anti-inflammatory drugs into the posterior fossa in a patient affected by type I Arnold Chiari malformation. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420929015DOI Listing

The ICHD definition of 'facial pain' should be revised.

Cephalalgia 2020 May 22:333102420928080. Epub 2020 May 22.

Department of Systems Neuroscience, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420928080DOI Listing

A case report of a transient splenial lesion related to HaNDL syndrome.

Cephalalgia 2020 May 22:333102420927023. Epub 2020 May 22.

Department of Neurology and Neurophysiology, Royal North Shore Hospital, St Leonards, NSW, Australia.

Background: Transient lesions in the splenium of the corpus callosum have been identified in many clinical cases, and often correspond to a metabolic insult to the brain. The syndrome of transient headache and neurological deficits with cerebrospinal fluid lymphocytosis (HaNDL syndrome) is a rare but under-recognised headache syndrome.

Case: A 47-year-old man presented to our hospital with a 2-week history of intermittent headache, and acute right sided hemisensory deficit. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420927023DOI Listing

ATP sensitive potassium (K) channel inhibition: A promising new drug target for migraine.

Cephalalgia 2020 Jun 16;40(7):650-664. Epub 2020 May 16.

Danish Headache Center, Department of Neurology, Glostrup Research Institute, Righospitalet Glostrup, Glostrup, Denmark.

Background: Recently, the adenosine triphosphate (ATP) sensitive potassium channel opener levcromakalim was shown to induce migraine attacks with a far higher incidence than any previous provoking agent such as calcitonin gene-related peptide. Here, we show efficacy of ATP sensitive potassium channel inhibitors in two validated rodent models of migraine.

Methods: In female spontaneous trigeminal allodynic rats, the sensitivity of the frontal region of the head was tested by an electronic von Frey filament device. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420925513DOI Listing

Mechanical punctate pain threshold is associated with headache frequency and phase in patients with migraine.

Cephalalgia 2020 May 16:333102420925540. Epub 2020 May 16.

Brain Research Center, National Yang-Ming University, Taipei, Taiwan.

Objective: Previous studies regarding the quantitative sensory testing are inconsistent in migraine. We hypothesized that the quantitative sensory testing results were influenced by headache frequency or migraine phase.

Methods: This study recruited chronic and episodic migraine patients as well as healthy controls. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420925540DOI Listing

Cluster headache in Asian populations: Similarities, disparities, and a narrative review of the mechanisms of the chronic subtype.

Cephalalgia 2020 May 12:333102420923646. Epub 2020 May 12.

Department of Neurology, Neuroscience Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Objective: Headache disorders like migraine show geographic and ethnic differences between Asian and European/North American countries. In cluster headache, these differences are rarely mentioned and discussed. This article aimed to review the characteristics of cluster headache in Asian countries and compare the clinical features to those in European and North American populations. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420923646DOI Listing

Stabbing facial pain reminiscent of primary stabbing headache.

Cephalalgia 2020 May 6:333102420923643. Epub 2020 May 6.

Department of Systems Neuroscience, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Primary stabbing headache (PSH) is a transient and localized headache disorder. Facial variants of this rare pain syndrome have not been previously described. Four patients (n = 2 female, 2 male) presented themselves to our headache and facial pain outpatient clinic. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420923643DOI Listing

Dizziness and vertigo during the prodromal phase and headache phase of migraine: A systematic review and meta-analysis.

Cephalalgia 2020 Apr 29:333102420921855. Epub 2020 Apr 29.

BIDMC Comprehensive Headache Center, Department of Anesthesia, Critical Care and Pain Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA.

Objective: To assess the proportion of individuals who report dizziness and/or vertigo during the prodromal phase or headache phase of migraine.

Methods: The databases of MEDLINE and EMBASE were searched for studies on dizziness and/or vertigo during the prodromal phase or headache phase of migraine. Pooled relative frequencies were estimated using a random-effects meta-analysis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420921855DOI Listing

Identification of candidate proteomic markers in the serum of medication overuse headache patients: An exploratory study.

Cephalalgia 2020 Apr 29:333102420921847. Epub 2020 Apr 29.

Department of Surgery, Medicine, Dentistry and Morphological Science with Transplant Surgery, Oncology and Regenerative Medicine Relevance, Proteomic Lab, University of Modena and Reggio Emilia, Modena, Italy.

Purpose Of The Study: The pathophysiological mechanism of medication overuse headache is uncertain; no distinctive markers have been described right now. The aim of this study was to conduct proteomic analyses on serum samples from patients with medication overuse headache and healthy individuals. Specifically, mono- (SDS-PAGE) and two-dimensional gel electrophoresis (2-DE) followed by liquid chromatography tandem mass spectrometry (LC-MS/MS) were used to evaluate changes in serum proteins. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420921847DOI Listing

Vancouver Declaration II on Global Headache Patient Advocacy 2019.

Cephalalgia 2020 Apr 28:333102420921162. Epub 2020 Apr 28.

Lund University Hospital, Lund, Sweden.

In 2017, the International Headache Society convened a Global Patient Advocacy Summit (GPAS-1) to begin a collaborative effort involving patients, patient advocates, patient advocacy organizations, healthcare professionals, scientists, professional pain, neurology, and headache societies, pharmaceutical manufacturers, and regulatory agencies to advance issues of importance to patients affected by headache worldwide. In September 2019, the second Global Patient Advocacy Summit (GPAS-2) was convened to revisit issues from the inaugural meeting, assess the progress of the International Headache Society Global Patient Advocacy Coalition (IHS-GPAC) in meeting the goals set forth therein, and discuss strategies for achieving established goals and supporting future development. Short- and long-term mandates from the first Summit were realized, including publishing the Vancouver Declaration on Global Headache Patient Advocacy 2018, determining the governing and operational structures of the IHS-GPAC, and helping to facilitate the first World Federation of Neurology World Brain Day dedicated to migraine. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420921162DOI Listing

Assessment of immunogenicity from galcanezumab phase 3 trials in patients with episodic or chronic migraine.

Cephalalgia 2020 Apr 27:333102420920642. Epub 2020 Apr 27.

Eli Lilly and Company, Indianapolis, IN, USA.

Background: This analysis characterizes the immunogenicity profile of galcanezumab, a humanized monoclonal antibody that selectively binds calcitonin gene-related peptide and inhibits its activity, in phase 3 migraine trials.

Methods: Immunogenicity data were analyzed from baseline and double-blind, placebo-controlled phases of the 3-month chronic migraine study REGAIN, the 6-month episodic migraine studies EVOLVE-1 and EVOLVE-2, and from baseline and open-label phases of the 12-month chronic and episodic migraine Study CGAJ. The incidence of baseline antidrug antibodies, treatment-emergent antidrug antibodies, neutralizing antidrug antibodies, and the effect of antidrug antibody titer on pharmacokinetics and pharmacodynamics were assessed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420920642DOI Listing

Clinic-based characterization of continuous headache in children and adolescents: Comparing youth with chronic migraine to those with new daily persistent headache.

Cephalalgia 2020 Apr 26:333102420920644. Epub 2020 Apr 26.

Cincinnati Children's Headache Center, Cincinnati, OH, USA.

Objective: To describe the headache characteristics and functional disability of a large sample of treatment-seeking youth with continuous headache and compare these factors across diagnostic subgroups of chronic migraine and new daily persistent headache.

Methods: This retrospective study utilized clinical information (e.g. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420920644DOI Listing

International Classification of Headache Disorders - ICHD-4 .

Cephalalgia 2020 Apr 22:333102420919098. Epub 2020 Apr 22.

University of Münster, Münster, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420919098DOI Listing

Low frequency activation of the sphenopalatine ganglion does not induce migraine-like attacks in migraine patients.

Cephalalgia 2020 Apr 22:333102420921156. Epub 2020 Apr 22.

Danish Headache Center and Department of Neurology, Rigshospitalet Glostrup, Faculty of Health and Medical Sciences, University of Copenhagen, Glostrup, Denmark.

Introduction: Cephalic autonomic symptoms occur in 27‒73% of migraine patients during attacks. The role of parasympathetic activation in migraine attack initiation remains elusive. Low frequency stimulation of the sphenopalatine ganglion increases parasympathetic outflow. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420921156DOI Listing

Prevalence and socio-demographic characteristics of persons who have never had a headache among healthy voluntary blood donors - a population-based study.

Cephalalgia 2020 Apr 20:333102420920653. Epub 2020 Apr 20.

Danish Headache Center, Department of Neurology, Rigshospitalet, Glostrup, Denmark.

Introduction: Headache is an extremely prevalent disorder with a lifetime prevalence of 90-99%. However, a small fraction of people never experiences a headache. Research on people without headache could uncover protective factors in headache, but to our knowledge no study on headache-free individuals has been published. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420920653DOI Listing

Cortical morphological changes in chronic migraine in a Taiwanese cohort: Surface- and voxel-based analyses.

Cephalalgia 2020 May 16;40(6):575-585. Epub 2020 Apr 16.

Department of Neurology, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan.

Background: Previous voxel- or surface-based morphometric analysis studies have revealed alterations in cortical structure in patients with chronic migraine, yet with inconsistent results. The discrepancies may be derived partly from the sample heterogeneity. Employing both methods in a clinically homogenous group may provide a clearer view. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420920005DOI Listing

Paroxysmal headache with extracephalic irradiation: Proposal for a new variant of epicrania fugax in a series of five patients.

Cephalalgia 2020 Apr 15:333102420920646. Epub 2020 Apr 15.

Neurology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain.

Background: Epicrania fugax consists of brief paroxysms of pain, which radiate in a line or in zigzag trajectory across the surface of the scalp or the face.

Methods: A prospective, descriptive study was performed in five patients presenting with an epicrania fugax-type pain with extracephalic irradiation.

Results: All patients were women, and the mean age at onset was 59. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420920646DOI Listing

Increased neck muscle stiffness in migraine patients with ictal neck pain: A shear wave elastography study.

Cephalalgia 2020 May 15;40(6):565-574. Epub 2020 Apr 15.

Danish Headache Center, Department of Neurology, Rigshospitalet-Glostrup, Faculty of Health and Medical Sciences, University of Copenhagen, Glostrup, Denmark.

Background: Ictal neck pain is a frequent symptom reported by half of migraine patients. It is unknown if neck pain is caused by peripheral or central mechanisms. Neck muscle stiffness can be investigated with ultrasound shear wave elastography. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420919998DOI Listing

Nutcracker syndrome mimicking new daily persistent headache: A case report.

Cephalalgia 2020 Apr 15:333102420918554. Epub 2020 Apr 15.

Headache and Facial Pain Group, UCL Queen Square Institute of Neurology and National Hospital for Neurology and Neurosurgery, London, United Kingdom.

Introduction: Compression of the duodenum and left renal vein between the aorta and superior mesenteric artery usually leads to symptoms of proximal bowel obstruction or hematuria and, more rarely, nonspecific mild headaches.

Case: A young woman presented with new daily persistent headache refractory to numerous pharmacological treatments, onabotulinumtoxinA, nerve blocks, and occipital nerve stimulation. Following several years of daily severe headache, worsening abdominal pain and intolerance for food intake led to the discovery of aortomesenteric compression. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420918554DOI Listing

EXPRESSION OF CONCERN: Articles by Y Sato in .

Authors:

Cephalalgia 2020 May 14;40(6):635. Epub 2020 Apr 14.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420920183DOI Listing

The use of anti-epileptic drugs in prevention of migraine in children and adolescents.

Cephalalgia 2020 Jun 10;40(7):762-763. Epub 2020 Apr 10.

Pediatrics Center of Excellence, Department of Pediatric Neurology, Children's Medical Center, Growth and Development Research Center, Tehran University of Medical Sciences, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102420918526DOI Listing
June 2020
4.891 Impact Factor